Quantbot Technologies’s Vanda Pharmaceuticals VNDA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-7,300
| Closed | -$30K | – | 1945 |
|
|
2024
Q1 | $30K | Buy |
+7,300
| New | +$29.2K | ﹤0.01% | 1383 |
|
|
2023
Q4 | – | Sell |
-5,500
| Closed | -$23.8K | – | 2032 |
|
|
2023
Q3 | $23.8K | Sell |
5,500
-6,300
| -53% | -$35K | ﹤0.01% | 1333 |
|
|
2023
Q2 | $77.8K | Buy |
11,800
+5,300
| +82% | +$34K | 0.01% | 1231 |
|
|
2023
Q1 | $44.1K | Buy |
+6,500
| New | +$45.7K | ﹤0.01% | 1270 |
|
|
2022
Q4 | – | Sell |
-9,200
| Closed | -$90K | – | 2146 |
|
|
2022
Q3 | $90K | Buy |
+9,200
| New | +$97.1K | 0.01% | 1120 |
|
|
2021
Q2 | – | Sell |
-6,659
| Closed | -$100K | – | 1895 |
|
|
2021
Q1 | $100K | Buy |
+6,659
| New | +$108K | 0.01% | 882 |
|
|
2020
Q3 | – | Sell |
-758
| Closed | -$8K | – | 1667 |
|
|
2020
Q2 | $8K | Buy |
+758
| New | +$8.58K | ﹤0.01% | 956 |
|
|
2020
Q1 | – | Sell |
-5,200
| Closed | -$85K | – | 1419 |
|
|
2019
Q4 | $85K | Buy |
5,200
+1,159
| +29% | +$17.5K | 0.01% | 852 |
|
|
2019
Q3 | $53K | Buy |
+4,041
| New | +$56.3K | 0.01% | 957 |
|
|
2018
Q4 | – | Sell |
-3,525
| Closed | -$80K | – | 1444 |
|
|
2018
Q3 | $80K | Sell |
3,525
-5,567
| -61% | -$114K | 0.01% | 938 |
|
|
2018
Q2 | $173K | Buy |
+9,092
| New | +$152K | 0.01% | 759 |
|
|
2018
Q1 | – | Sell |
-679
| Closed | -$10K | – | 1539 |
|
|
2017
Q4 | $10K | Sell |
679
-2,725
| -80% | -$40.4K | ﹤0.01% | 1109 |
|
|
2017
Q3 | $60K | Buy |
3,404
+1,647
| +94% | +$27.6K | 0.01% | 940 |
|
|
2017
Q2 | $28K | Sell |
1,757
-3,547
| -67% | -$51.1K | ﹤0.01% | 970 |
|
|
2017
Q1 | $74K | Sell |
5,304
-1,532
| -22% | -$21.8K | 0.01% | 845 |
|
|
2016
Q4 | $109K | Buy |
6,836
+6,677
| +4,199% | +$107K | 0.01% | 686 |
|
|
2016
Q3 | $2K | Buy |
+159
| New | +$2.14K | ﹤0.01% | 1038 |
|
|
2016
Q1 | – | Sell |
-6,220
| Closed | -$57K | – | 1431 |
|
|
2015
Q4 | $57K | Buy |
6,220
+4,120
| +196% | +$41.1K | 0.01% | 773 |
|
|
2015
Q3 | $23K | Sell |
2,100
-10,613
| -83% | -$130K | ﹤0.01% | 1013 |
|
|
2015
Q2 | $161K | Buy |
+12,713
| New | +$137K | 0.03% | 503 |
|
|
2015
Q1 | – | Sell |
-16,601
| Closed | -$237K | – | 1372 |
|
|
2014
Q4 | $237K | Buy |
+16,601
| New | +$196K | 0.08% | 371 |
|
|
2014
Q2 | – | Sell |
-1,900
| Closed | -$30K | – | 1401 |
|
|
2014
Q1 | $30K | Buy |
+1,900
| New | +$27K | 0.01% | 903 |
|
Other funds holding VNDA
TCM
NCM
Quantbot Technologies's VNDA Position: Q2 2024 in Review
Quantbot Technologies sold out of Vanda Pharmaceuticals (VNDA) in Q2 2024, closing a stake of 7,300 shares — an estimated $30K sold.
Quantbot Technologies first reported a position in VNDA in Q1 2014 and held it in 22 quarters. The position peaked at $237K in Q4 2014. 148 funds tracked by Wall St. Rank hold VNDA as of Q2 2024.
- Quantbot Technologies reported no remaining Vanda Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
- Quantbot Technologies sold 7,300 Vanda Pharmaceuticals shares in Q2 2024, an estimated $30K.
- Quantbot Technologies first reported a position in Vanda Pharmaceuticals in Q1 2014 and held it in 22 quarters.
- Quantbot Technologies's Vanda Pharmaceuticals position peaked at $237K in Q4 2014.
- 148 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q2 2024.
Based on Quantbot Technologies's 13F filing for Q2 2024, filed 9 Aug 2024.